Marc Trudeau
Impact in
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
-
- Cancer survivorship and care
- Drug Transport and Resistance Mechanisms
- Lymphatic System and Diseases
Papers in ⓘ
- Oncology 8
- Cancer survivorship and care 3
- Drug Transport and Resistance Mechanisms 2
- Colorectal Cancer Treatments and Studies 1
- Lymphatic System and Diseases 1
-
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- Jeff K. Vallance (3 shared papers)Nicole Culos-Reed (3 shared papers)G. Stanimir (2 shared papers)Robert J. Seymour (1 shared paper)Carolyn Freeman (2 shared papers)Ted N. Roman (2 shared papers)Brenda Clark (2 shared papers)Luís Souhami (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Investigational New Drugs (1 paper)Psychology Health & Medicine (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Marc Trudeau
14 papers receiving 276 citations
Peers
Comparison fields: 5 of 60
- Obstetrics and Gynecology 73
- Oncology 142
- Pediatrics, Perinatology and Child Health 55
- Reproductive Medicine 22
- Biomaterials 25
Countries citing papers authored by Marc Trudeau
This map shows the geographic impact of Marc Trudeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Trudeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Trudeau more than expected).
Fields of papers citing papers by Marc Trudeau
This network shows the impact of papers produced by Marc Trudeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Trudeau. The network helps show where Marc Trudeau may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Trudeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 74 | |
| 2 | Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen. | 1998 | 38 |
| 3 | 2012 | 36 | |
| 4 | 2005 | 33 | |
| 5 | 2002 | 21 | |
| 6 | 2012 | 21 | |
| 7 | 2011 | 19 | |
| 8 | 1996 | 19 | |
| 9 | The Economic Impact of University Research. | 1998 | 8 |
| 10 | 2011 | 6 | |
| 11 | 2016 | 3 | |
| 12 | 1992 | 3 | |
| 13 | 2011 | 3 | |
| 14 | 2003 | 1 | |
| 15 | 2020 | 0 |
About Marc Trudeau
Marc Trudeau is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 15 papers that have together received 285 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Cancer survivorship and care (3 papers), Prostate Cancer Treatment and Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Colorectal Cancer Treatments and Studies (1 paper) and Lymphatic System and Diseases (1 paper). The work is most often cited by research in Obstetrics and Gynecology (73 citations), Oncology (142 citations), Pediatrics, Perinatology and Child Health (55 citations), Reproductive Medicine (22 citations) and Biomaterials (25 citations). Marc Trudeau has collaborated with scholars based in Canada and United States. Frequent co-authors include Jeff K. Vallance, Nicole Culos-Reed, G. Stanimir, Robert J. Seymour, Carolyn Freeman, Ted N. Roman, Brenda Clark, Luís Souhami, Brian Leyland‐Jones and Camille Granvil. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Investigational New Drugs, Psychology Health & Medicine and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.